Mauna Kea Technologies SAS

Mauna Kea Technologies SA manufactures and sells medical devices in Europe and internationally. Its devices serve gastroenterology, pulmonology, and urology applications. The product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables in vivo cellular visualization, allowing doctors to monitor disease evolution over time, evaluate reactions as they occur, classify areas of uncertainty, guide surgical interventions, and help diagnose and treat patients. The company was incorporated in 2000 and is headquartered in Paris, France.